MHRA

The Medicines and Healthcare Products Regulatory Agency

MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is the government agency responsible for ensuring that medicines and medical devices work, and are acceptably safe.

The MHRA keep watch over medicines and devices, and take any necessary action to protect the public promptly if there is a problem. No product is risk-free. Underpinning all our work lie robust and fact-based judgements to ensure that the benefits to patients and the public justify the risks.

Aims

Our aims are:

Protecting public health through regulation, with acceptable benefit-risk profiles for medicines and devices
Promoting public health by helping people who use these products to understand their risks and benefits
Improving public health by encouraging and facilitating developments in products that will benefit people

Objectives

Our strategic objectives are to:

Safeguard public health through our primary role in ensuring that the products we regulate meet required standards, that they work and are acceptably safe
Carry out our communication role through the provision of accurate, timely and authoritative information to healthcare professionals, patients and the public
Support research, ensuring through the application of Better Regulation principles that regulation does not stifle innovation
Influence the shape of the future regulatory framework through use of our effective European and International relationships
Run an organisation with a skilled and equipped workforce that is fit for the future

Our main activities are:

Assessing the safety, quality and efficacy of medicines, and authorising their sale or supply in the UK for human use
Overseeing the UK Notified Bodies that audit medical device manufacturers
Operating post-marketing surveillance and other systems for reporting, investigating and monitoring adverse reactions to medicines and adverse incidents involving medical devices and taking any necessary action to safeguard public health, for example through safety warnings, removing or restricting the availability of products or improving designs
Operating a proactive compliance programme for medical devices
Operating a quality surveillance system to sample and test medicines and to address quality defects, monitoring the safety and quality of imported unlicensed medicines and investigating Internet sales and potential counterfeiting of medicines
Regulating clinical trials of medicines and medical devices
Monitoring and ensuring compliance with statutory obligations relating to medicines and medical devices through inspection, taking enforcement action where necessary
Promoting good practice in the safe use of medicines and medical devices
Managing the General Practice Research Database (GPRD) and the British Pharmacopoeia (BP) and contributing to the development of performance standards for medical devices
Offering scientific, technical and regulatory advice on medicines and medical devices; and
Providing the public and professions with authoritative information to enable informed dialogue on treatment choices

10-2 Market Towers
1 Nine Elms Lane
London
SW8 5NQ

Tel: 020 7084 2000 (weekdays 0900 -1700)
Tel: 020 7210 3000 (other times)
Fax: 020 7084 2353
info@mhra.gsi.gov.uk
www.mhra.gov.uk

Contact MHRA

First Name*

Last Name*

Email*

Telephone Number

Role In Purchasing*

Job Title*

Job Function*

Company*

Company Activity*

Country*

Comments

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.

Address Line 1

Address Line 2

City

County/State

Postcode/ZIP Code

Fax

Company Turnover

No of Employees

Email Updates

Please confirm which of the FREE email services you would like to receive from us, you can unsubscribe at any time:

Pharmaceutical Business review Daily Update

Pharmaceutical Business review Weekly Round-up

magazinePharmaceutical Business review Magazine

Confirmation

Finally, complete a quick security check and confirm terms and conditions:

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.

If you would like to hear from carefully selected third party companies, check this box

Drug Discovery

Research & Development

Ring Therapeutics signs partnerships to advance R&D in biomedical sciences

insitro collaborates with Lilly on metabolic disease treatments

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Torii submits NDA for molluscum contagiosum treatment therapy in Japan

Neuvivo files NDA seeking FDA approval for ALS treatment

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer

PCI Pharma announces bottling line expansion at Rockford site

Suppliers

No data found

MHRA

The Medicines and Healthcare Products Regulatory Agency

Aims

Objectives

Top Products from MHRA

Optional Data

Email Updates

Confirmation

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found

MHRA

The Medicines and Healthcare Products Regulatory Agency

MHRA

Aims

Objectives

Top Products from MHRA

Contact MHRA

Optional Data

Email Updates

Confirmation

MHRA

The Medicines and Healthcare Products Regulatory Agency